
Showing 130 – 140 of 1307 results
-
Thinking About Quantitative Tightening Feb 2022
At the January FOMC meeting, the Fed announced that it is keen to “significantly” shrink the size of its balance sheet.
-
Real Estate Steps Up to Rising Demand for Green Cities
-
Reaching Out More Valuable Than Ever
William Blair kicked off its 2019 Courageous Conversations series, inspirational talks to nurture an inclusive and diverse workplace, on April 1 with University of Chicago Professor Nicholas Epley.
-
William Blair Diversity Talk Features Chicago Jazz Institute Director
William Blair wrapped up its 2020 virtual speaker series promoting the value of diversity and inclusion with a conversation about Chicago’s historic and thriving jazz scene with Heather Ireland Robinson, executive director of the Jazz Institute of Chicago.
-
Evans Food Group and Highlander Partners
William Blair acted as the exclusive financial advisor to Evans Food Group (Evans), a portfolio company of Wind Point Partners, in connection with its sale to Highlander Partners.
-
MDSL and Oak Hill Capital Partners
William Blair acted as the exclusive financial advisor to MDSL, a portfolio company of Sumeru Equity Partners (SEP), in connection with its pending sale to Oak Hill Capital Partners and planned merger with Calero Software.
-
Syndigo and Summit Partners
William Blair acted as the exclusive financial advisor to Syndigo, a portfolio company of The Jordan Company (TJC), in connection with its investment from Summit Partners.
-
Varonis Systems Inc Initiation
William Blair & Company initiated research coverage of Varonis Systems, Inc. (VRNS $89.00), an enterprise software vendor that safeguards an enterprise’s underlying data, provides more visibility into that data, and ensures compliance with regulatory mandates such as GDPR.
-
ContextLogic Inc Initiation
William Blair & Company initiated research coverage of ContextLogic Inc., which does business under the name Wish (WISH $20.93). Wish is an online e-commerce platform serving over 100 million monthly active users in 100 countries.
-
Biotech IPOs in 2021 Outpacing Last Year’s Record as Advances in Technology Drive Investor Interest
Enthusiasm in biotech discoveries has been a boom for biotech initial public offerings.